- Home
- ACNB vs VOR Comparison
ACNB vs VOR Comparison
Compare ACNB & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACNB | VOR |
|---|---|---|
| Founded | 1857 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 522.8M | 562.6M |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ACNB | VOR |
|---|---|---|
| Price | $46.48 | $13.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 10 |
| Target Price | $49.50 | ★ $64.78 |
| AVG Volume (30 Days) | 31.4K | ★ 549.7K |
| Earning Date | 04-23-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.27% | N/A |
| EPS Growth | N/A | ★ 2.86 |
| EPS | ★ 3.60 | N/A |
| Revenue | ★ $191,821,000.00 | N/A |
| Revenue This Year | $13.18 | N/A |
| Revenue Next Year | $1.91 | N/A |
| P/E Ratio | $12.93 | ★ N/A |
| Revenue Growth | ★ 45.10 | N/A |
| 52 Week Low | $35.70 | $0.13 |
| 52 Week High | $53.89 | $49.95 |
Technical Indicators
Market Signals| Indicator | ACNB | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 30.98 | 43.87 |
| Support Level | $42.84 | $11.27 |
| Resistance Level | $46.53 | $14.73 |
| Average True Range (ATR) | 1.49 | 1.16 |
| MACD | -0.51 | -0.17 |
| Stochastic Oscillator | 7.33 | 10.66 |
Price Performance
Historical ComparisonAbout ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.